| Last Trade: |
22.40 |
| Trade Time: |
May 18 4:00 PM Eastern Daylight Time |
| Change: |
0.00 (0.00 %) |
| Prev Close: |
22.40 |
| Open: |
0.00 |
| Bid: |
0.00 |
| Ask: |
0.00 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
3/16/2012
|
LOGAN MARK B
|
Director
|
2,000
|
$3.13
|
4.17%
|
|
3/16/2012
|
LOGAN MARK B
|
Director
|
-8,000
|
$20.32
|
-14.29%
|
|
3/16/2012
|
LOGAN MARK B
|
Director
|
-2,000
|
$20.32
|
-4.00%
|
|
3/16/2012
|
LOGAN MARK B
|
Director
|
4,000
|
$3.27
|
8.33%
|
|
3/16/2012
|
LOGAN MARK B
|
Director
|
-4,000
|
$20.32
|
-7.69%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (VVUS), click here.
-
Vivus Inc. (VVUS) received a major boost when the U.S. Food and Drug Administration (FDA) approved its erectile dysfunction (ED) drug, Stendra (avanafil). The company is also seeking to get the ...
Read More »
-
Vivus Inc. (VVUS) received a major boost when the U.S. Food and Drug Administration (FDA) approved its erectile dysfunction (ED) drug, Stendra (avanafil). The company is also seeking to get the ...
Read More »
-
The risks are huge, but well worth the potential rewards, writes MoneyShow.com senior editor Igor Greenwald.
Let’s set out to design, from scratch, a group of stocks that would have least app ...
Read More »
-
While lesser-known stocks have put up astronomical performances since the turn of the year, many bigger name companies have also seen amazing returns.
Read More »
-
Nutrisystem's membership weakness is a worrisome sign.
Read More »
-
Sometimes it's easy to buy a story instead of buying a stock...make sure you know the difference, and opt for the latter, writes Timothy Lutts of Cabot Wealth Advisory.
A couple weeks ago, there w ...
Read More »
Free Reports
|
|
